D Snook

1.1k total citations
21 papers, 866 citations indexed

About

D Snook is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, D Snook has authored 21 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in D Snook's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and HER2/EGFR in Cancer Research (4 papers). D Snook is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and HER2/EGFR in Cancer Research (4 papers). D Snook collaborates with scholars based in United Kingdom, Greece and United States. D Snook's co-authors include A. A. Epenetos, G. Hooker, V Hird, Gregory Sivolapenko, Claude F. Meares, B Dhokia, Nigel Courtenay-Luck, Haralabos P. Kalofonos, Agamemnon A. Epenetos and H Lambert and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

D Snook

21 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Snook United Kingdom 14 701 228 202 135 129 21 866
G. Hooker United Kingdom 13 663 0.9× 228 1.0× 178 0.9× 113 0.8× 132 1.0× 17 847
G.L. Buraggi Italy 15 583 0.8× 310 1.4× 205 1.0× 113 0.8× 115 0.9× 43 811
C. Curtet France 17 557 0.8× 170 0.7× 150 0.7× 145 1.1× 97 0.8× 36 880
David M. Goldenberg United States 11 381 0.5× 149 0.7× 123 0.6× 99 0.7× 87 0.7× 14 571
Philippe Thédrez France 17 464 0.7× 120 0.5× 100 0.5× 63 0.5× 92 0.7× 31 617
Lisa B. Shih United States 17 803 1.1× 363 1.6× 340 1.7× 179 1.3× 125 1.0× 29 1.1k
R M Sharkey United States 18 695 1.0× 216 0.9× 151 0.7× 124 0.9× 130 1.0× 21 818
G. Rowlinson United Kingdom 7 285 0.4× 122 0.5× 94 0.5× 53 0.4× 49 0.4× 10 435
Sébastien Gouard France 18 450 0.6× 259 1.1× 159 0.8× 33 0.2× 178 1.4× 37 758
A Harłozińska Poland 14 103 0.1× 219 1.0× 234 1.2× 66 0.5× 67 0.5× 55 587

Countries citing papers authored by D Snook

Since Specialization
Citations

This map shows the geographic impact of D Snook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Snook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Snook more than expected).

Fields of papers citing papers by D Snook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Snook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Snook. The network helps show where D Snook may publish in the future.

Co-authorship network of co-authors of D Snook

This figure shows the co-authorship network connecting the top 25 collaborators of D Snook. A scholar is included among the top collaborators of D Snook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Snook. D Snook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kosmas, Christos, et al.. (1995). Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy.. PubMed. 36(5). 746–53. 14 indexed citations
2.
Kalofonos, Haralabos P., Christos Kosmas, V Hird, D Snook, & A. A. Epenetos. (1994). Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: Immunolocalisation, pharmacokinetics and immune response. European Journal of Cancer. 30(12). 1842–1850. 9 indexed citations
3.
Hird, V, Anthony Maraveyas, D Snook, et al.. (1993). Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. British Journal of Cancer. 68(2). 403–406. 132 indexed citations
4.
Snook, D, et al.. (1993). Technetium-99m-labeled antibodies. Cell Biophysics. 22(1-3). 49–59. 1 indexed citations
5.
Kosmas, Christos, D Snook, Nigel Courtenay-Luck, et al.. (1992). Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.. PubMed. 52(4). 904–11. 74 indexed citations
6.
Hird, V, Martine Verhoeyen, R.A. Badley, et al.. (1991). Tumour localisation with a radioactively labelled reshaped human monoclonal antibody. British Journal of Cancer. 64(5). 911–914. 33 indexed citations
7.
Kalofonos, Haralabos P., Christos Kosmas, Aristotle Bamias, et al.. (1991). Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase.. PubMed. 34(4). 294–8. 3 indexed citations
8.
Stewart, John S., V Hird, D Snook, et al.. (1990). Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.. Journal of Clinical Oncology. 8(12). 1941–1950. 102 indexed citations
9.
Kalofonos, Haralabos P., Mary Rusckowski, Gregory Sivolapenko, et al.. (1990). Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.. PubMed. 31(11). 1791–6. 114 indexed citations
10.
Hird, V, et al.. (1990). Intraperitoneal radioimmunotherapy for ovarian cancer. International Journal of Gynecology & Obstetrics. 31(1). 96–96. 4 indexed citations
11.
Kalofonos, Haralabos P., Mary Rusckowski, Gregory Sivolapenko, et al.. (1990). Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med. 2 indexed citations
12.
Meares, Claude F., Min K. Moi, David L. Kukis, et al.. (1990). Macrocyclic chelates of radiometals for diagnosis and therapy.. PubMed. 10. 21–6. 48 indexed citations
13.
Stewart, J.S.W., V Hird, D Snook, et al.. (1989). Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies. International Journal of Radiation Oncology*Biology*Physics. 16(2). 405–413. 88 indexed citations
14.
Wilson, Charles B., Simon Stewart, Katherine A. Vallis, et al.. (1989). High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer. Lung Cancer. 5(2-3). 111–111. 7 indexed citations
15.
Malamitsi, Julia, Stelios Fotiou, Pavlos Papakostas, et al.. (1988). Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.. PubMed. 29(12). 1910–5. 26 indexed citations
16.
Kalofonos, Haralabos P., Gregory Sivolapenko, D Snook, et al.. (1988). Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.. PubMed. 48(7). 1977–84. 33 indexed citations
17.
Rowlinson, G., et al.. (1988). Radiolocalisation of an anti-CEA Monoclonal Antibody (FO23C5) and its Fragments in a Colon Carcinoma Xenograft Model. The International Journal of Biological Markers. 3(4). 259–264. 2 indexed citations
18.
Pectasides, Dimitrios, Simon Stewart, Nigel Courtenay-Luck, et al.. (1986). Antibody-guided irradiation of malignant pleural and pericardial effusions. British Journal of Cancer. 53(6). 727–732. 45 indexed citations
19.
Epenetos, Agamemnon A., G. Hooker, H. Durbin, et al.. (1985). INDIUM-111 LABELLED MONOCLONAL ANTIBODY TO PLACENTAL ALKALINE PHOSPHATASE IN THE DETECTION OF NEOPLASMS OF TESTIS, OVARY, AND CERVIX. The Lancet. 326(8451). 350–353. 60 indexed citations
20.
Courtenay-Luck, Nigel, A. A. Epenetos, K.E. Halnan, et al.. (1984). Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund.. PubMed. 1(8392). 1441–3. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026